PHS
DBVT

PFM Health Sciences’s DBV Technologies DBVT Stock Holding History

PFM Health Sciences’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,397
Closed -$9.75M – 71
2015
Q3 		$9.75M Buy
+27,397
New +$10.8M 0.27% 57

Other funds holding DBVT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

PFM Health Sciences's DBVT Position: Q4 2015 in Review

PFM Health Sciences sold out of DBV Technologies (DBVT) in Q4 2015, closing a stake of 27,397 shares — an estimated $9.75M sold.

PFM Health Sciences first reported a position in DBVT in Q3 2015 and held it in 1 quarter. The position peaked at $9.75M in Q3 2015. 65 funds tracked by Wall St. Rank hold DBVT as of Q4 2015.

  • PFM Health Sciences reported no remaining DBV Technologies position as of Q4 2015 after selling out during the quarter.
  • PFM Health Sciences sold 27,397 DBV Technologies shares in Q4 2015, an estimated $9.75M.
  • PFM Health Sciences first reported a position in DBV Technologies in Q3 2015 and held it in 1 quarter.
  • PFM Health Sciences's DBV Technologies position peaked at $9.75M in Q3 2015.
  • 65 funds tracked by Wall St. Rank held DBV Technologies as of Q4 2015.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.